Temporal Trends and Projections of Bladder Cancer Burden in China from 1990 to 2030: Findings from the Global Burden of Disease Study

References

• Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: a review. JAMA. 2020;324(19):1980–1991. doi:10.1001/jama.2020.17598
   PubMed Web of Science ®Google Scholar
• Saginala K, Barsouk A, Aluru JS, Rawla P, Padala SA, Barsouk A. Epidemiology of bladder cancer. Med Sci. 2020;8(1):15. doi:10.3390/medsci8010015
   Google Scholar
• Lopez-Beltran A, Henriques V, Montironi R, Cimadamore A, Raspollini MR, Cheng L. Variants and new entities of bladder cancer. Histopathology. 2019;74(1):77–96. doi:10.1111/his.13752
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Zi H, He SH, Leng XY, et al. Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990–2019. Mil Med Res. 2021;8(1):60. doi:10.1186/s40779-021-00354-z
   Web of Science ®Google Scholar
• Safiri S, Kolahi A-A, Naghavi M. Global, regional and national burden of bladder cancer and its attributable risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease study 2019. BMJ Glob Health. 2010;105(3):300–308. doi:10.1111/j.1464-410X.2009.09076.x
   Web of Science ®Google Scholar
• Shariat SF, Sfakianos JP, Droller MJ, Karakiewicz PI, Meryn S, Bochner BH. The effect of age and gender on bladder cancer: a critical review of the effect of age and gender on bladder cancer: a critical review of the literature. BJU Int. 2010;105(3):300–308. doi:10.1111/j.1464-410X.2009.09076.x
   PubMed Web of Science ®Google Scholar
• Ghadimi T, Gheitasi B, Nili S, Karimi M, Ghaderi E. Occupation, smoking, opium, and bladder cancer: a case-control study. South Asian J Cancer. 2015;4(3):111–114. doi:10.4103/2278-330X.173174
   Google Scholar
• Cogliano VJ, Baan R, Straif K, et al. Preventable exposures associated with human cancers. J Natl Cancer Inst. 2011;103(24):1827–1839. doi:10.1093/jnci/djr483
   PubMedGoogle Scholar
• Richters A, Aben K, Kiemeney L. The global burden of urinary bladder cancer: an update. World J Urol. 2020;38(8):1895–1904. doi:10.1007/s00345-019-02984-4
   PubMed Web of Science ®Google Scholar
• Kocarnik JM, Compton K, Dean FE, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019. JAMA Oncol. 2022;8(3):420–444. doi:10.1001/jamaoncol.2021.6987
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
   PubMed Web of Science ®Google Scholar
• Liu X, Jiang J, Yu C, et al. Secular trends in incidence and mortality of bladder cancer in China, 1990–2017: a joinpoint and age-period-cohort analysis. Cancer Epidemiol. 2019;61:95–103. doi:10.1016/j.canep.2019.05.011
   PubMed Web of Science ®Google Scholar
• Xu H, Li K, Liang Y, Dong H, Chen Y. Analysis on incidence of bladder cancer in Guangzhou City and its trend from 2004 to 2016. Chin Cancer. 2019;28(12):913–917. doi:10.11735/j.issn.1004-0242.2019.12.A006
   Google Scholar
• GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–1222. doi:10.1016/s0140-6736(20)30925-9
   PubMed Web of Science ®Google Scholar
• Yang X, Fang Y, Chen H, et al. Global, regional and national burden of anxiety disorders from 1990 to 2019: results from the global burden of disease study 2019. Epidemiol Psychiatr Sci. 2021;30:e36. doi:10.1017/S2045796021000275
   PubMed Web of Science ®Google Scholar
• Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71(1):96–108. doi:10.1016/j.eururo.2016.06.010
   PubMed Web of Science ®Google Scholar
• Wong M, Fung F, Leung C, Cheung W, Goggins W, Ng C. The global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and the global epidemiology of bladder cancer: a joinpoint regression analysis of its incidence and mortality trends and projection. Sci Rep. 2018;8(1):1129–1140. doi:10.1038/s41598-018-19199-z
   PubMed Web of Science ®Google Scholar
• Li H, Zheng R, Du L, et al. Prevalence and trend of bladder cancer in China. Zhonghua Zhong Liu Za Zhi. 2021;43(3):293–298. doi:10.3760/cma.j.cn112152-20200421-00362
   Google Scholar
• Fajkovic H, Halpern JA, Cha EK, et al. Impact of gender on bladder cancer incidence, staging, and prognosis. World J Urol. 2011;29(4):457–463. doi:10.1007/s00345-011-0709-9
   PubMed Web of Science ®Google Scholar
• Dobruch J, Daneshmand S, Fisch M, et al. Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur Urol. 2016;69(2):300–310. doi:10.1016/j.eururo.2015.08.037
   PubMed Web of Science ®Google Scholar
• Samanic C, Kogevinas M, Dosemeci M, et al. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev. 2006;15(7):1348–1354. doi:10.1158/1055-9965
   PubMed Web of Science ®Google Scholar
• Zhao X, Wang Y, Liang C. Cigarette smoking and risk of bladder cancer: a dose-response meta-analysis. Int Urol Nephrol. 2022;54(6):1169–1185. doi:10.1007/s11255-022-03173-w
   Web of Science ®Google Scholar
• Ferrís J, Garcia J, Berbel O, Ortega JA. Constitutional and occupational risk factors associated with bladder cancer. Actas Urol Esp. 2013;37(8):513–522. doi:10.1016/j.acuro.2013.01.001
   Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.21551
   PubMed Web of Science ®Google Scholar
• Neuzillet Y, Geiss R, Caillet P, Paillaud E, Mongiat-Artus P. Epidemiological, pathological and prognostic characteristics of bladder cancer in elderly patients. Prog Urol. 2019;29(14):840–848. doi:10.1016/j.purol.2019.08.268
   Web of Science ®Google Scholar
• Cumberbatch MG, Rota M, Catto JW, La Vecchia C. The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks. Eur Urol. 2016;70(3):458–466. doi:10.1016/j.eururo.2015.06.042
   PubMed Web of Science ®Google Scholar
• Guo H. Tobacco control in China and the road to healthy China 2030. Int J Tuberc Lung Dis. 2020;24(3):271–277. doi:10.5588/ijtld.19.0106
   PubMed Web of Science ®Google Scholar
• Li W, Song F, Wang X, et al. Prevalence of metabolic syndrome among middle-aged and elderly adults in China: current status and temporal trends. Ann Med. 2018;50(4):345–353. doi:10.1080/07853890.2018.1464202
   PubMed Web of Science ®Google Scholar
• Pedroso TMA, Benvindo-Souza M, de Araújo Nascimento F, Woch J, Dos Reis FG. Cancer and occupational exposure to pesticides: a bibliometric study of the past 10 years. Environ Sci Pollut Res Int. 2022;29(12):17464–17475. doi:10.1007/s11356-021-17031-2
   Web of Science ®Google Scholar
• Jiang X, Castelao JE, Groshen S, et al. Urinary tract infections and reduced risk of bladder cancer in Los Angeles. Br J Cancer. 2009;100(5):834–839. doi:10.1038/sj.bjc.6604889
   Web of Science ®Google Scholar
• Scarselli A, Scanno P, Marinaccio A, Iavicoli S. Bladder cancer and occupational exposure: estimating the workers potentially at risk in Italy. Ann Ist Super Sanita. 2011;47(2):200–206. doi:10.4415/ANN_11_02_12
   Web of Science ®Google Scholar
• GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1223–1249. doi:10.1016/S0140-6736(20)30752-2
   PubMed Web of Science ®Google Scholar
• Hu X, Li G, Wu S. Advances in diagnosis and therapy for bladder cancer. Cancers. 2022;14(13):3181. doi:10.3390/cancers14133181
   Web of Science ®Google Scholar
• Koimtzis G, Alexandrou V, Chalklin CG, et al. The role of adjuvant single postoperative instillation of gemcitabine for non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Diagnostics. 2022;12(5):1154. doi:10.3390/diagnostics12051154
   Web of Science ®Google Scholar